About
Quentin Themans is a researcher at the University of Namur, affiliated with the Department of Chemistry and the Namur Medicine & Drug Innovation Center. His work focuses on structural and functional approaches to cancer-related metabolic enzymes.
Research interests include:
- Targeting serine metabolic pathway enzymes like PHGDH for anticancer therapy
- Crystallographic studies of IDO/TDO enzyme inhibition
- Repurposing disulfiram for enzyme-targeted cancer treatments
- Protein engineering for structural analysis
- Designing novel tetrameric enzyme inhibitors
- Investigating cysteine oxidation mechanisms
He has been actively involved in multiple research projects since 2014, including Télévie-funded initiatives.
0Publications listed
